HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus
- PMID: 2676192
- DOI: 10.1016/0092-8674(89)90874-x
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus
Abstract
The products of the human immunodeficiency virus (HIV) gag gene exist in a highly multimerized state in the mature virion. For that reason, they may represent a particularly suitable target for the generation of dominant negative mutants. A number of HIV site-directed Gag mutants did show interference with the production of infectious viral particles from cells in which they were cotransfected with a wild-type proviral DNA. Furthermore, cells constitutively expressing such HIV Gag mutants had an impaired ability to support HIV replication when infected with wild-type virus. The block was localized to the late stages of the virus life cycle. Such Gag variants could constitute prototypes for the development of anti-HIV intracellular immunization.
Similar articles
-
Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells.Microbes Infect. 2000 Oct;2(12):1419-23. doi: 10.1016/s1286-4579(00)01295-8. Microbes Infect. 2000. PMID: 11099927
-
Mutational analysis of HIV-1 gag proteins (review).Int J Mol Med. 2000 Sep;6(3):265-9. doi: 10.3892/ijmm.6.3.265. Int J Mol Med. 2000. PMID: 10934287 Review.
-
The potential of various HIV-1 mutants to inhibit the replication of wild-type virus.Biochem Biophys Res Commun. 1998 Jun 18;247(2):349-52. doi: 10.1006/bbrc.1998.8790. Biochem Biophys Res Commun. 1998. PMID: 9642129
-
Early replication block of human immunodeficiency virus type 1 in monkey cells.J Gen Virol. 1995 Nov;76 ( Pt 11):2723-30. doi: 10.1099/0022-1317-76-11-2723. J Gen Virol. 1995. PMID: 7595379
-
Suppression of HIV replication by dominant negative mutants of HIV-1 (review).Int J Mol Med. 1998 Sep;2(3):325-30. doi: 10.3892/ijmm.2.3.325. Int J Mol Med. 1998. PMID: 9855705 Review.
Cited by
-
Disease resistance in farm animals.Experientia. 1991 Sep 15;47(9):923-34. doi: 10.1007/BF01929883. Experientia. 1991. PMID: 1915776 Review.
-
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.J Virol. 1993 Aug;67(8):4945-55. doi: 10.1128/JVI.67.8.4945-4955.1993. J Virol. 1993. PMID: 8331734 Free PMC article.
-
Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5932-6. doi: 10.1073/pnas.91.13.5932. Proc Natl Acad Sci U S A. 1994. PMID: 8016092 Free PMC article.
-
A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.J Virol. 1995 Nov;69(11):6618-26. doi: 10.1128/JVI.69.11.6618-6626.1995. J Virol. 1995. PMID: 7474070 Free PMC article.
-
Gene therapy for HIV infections: Intracellular immunization.Can J Infect Dis. 1999 Jul;10(4):307-12. doi: 10.1155/1999/914379. Can J Infect Dis. 1999. PMID: 22346390 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources